Table 1.
Genotype | Birth weighta | Suvival | MN loss | Muscle innervation | Other phenotypes |
---|---|---|---|---|---|
WT/WT |
1.40 ± 0.01 g n = 183 |
Normal | Normal | Normal | NA |
P517L/WT |
1.37 ± 0.01 g n = 157 |
~90% survive to weaning | Onset at 1.5 years | TA denervation onset at 1 year | Malocclusion and rectal prolapse (all rare) |
Δ14/WT |
1.36 ± 0.01 g n = 173 |
~90% survive to weaning | Onset at 1.5 years | TA denervation onset at 1 year | Malocclusion and rectal prolapse (all rare) |
WT/KO |
1.34 ± 0.02 g n = 95 |
Normal | Normal | Normal | No known phenotype |
KO/KO |
1.00 ± 0.02 g n = 26 |
Perinatal lethal | Normal | Normal at birth | Hicks et al., 2000 |
P517L/KO |
1.15 ± 0.02 g n = 14 |
21 ± 12 d | NA | Normal at birth | Malocclusion, rectal prolapse and seizures |
Δ14/KO |
1.02 ± 0.02 g n = 13 |
Perinatal lethal; max survival ~1 week | NA | NA | NA |
P517L/P517L |
0.98 ± 0.02 g n = 26 |
Perinatal lethal | Normal at birth | Normal at birth | NA |
Δ14/Δ14 |
1.09 ± 0.01 g n = 50 |
~20% survive to weaning | Onset at 1 year | NA | Malocclusion, rectal prolapse and seizures |
P517L/Δ14 |
1.10 ± 0.02 g n = 44 |
Perinatal lethal; max survival ~3 weeks | NA | NA | NA |
MN-Δ14/WT: c14/WT; ChAT-Cre | NA | NA | Onset at 1.5 years | NA | NA |
MN-Δ14/Δ14: c14/c14; ChAT-Cre c14/Δ14; ChAT-Cre | NA | NA | Onset at 1 year | NA | NA |
MN-P517L/Δ14: P517L/c14; ChAT-Cre |
1.42 ± 0.03 g n = 28 |
~90% survive to weaning | Onset at 4 months | TA denervation onset at 4 months | Malocclusion, rectal prolapse and seizures (all rare) |
aMean ± s.e.m. n represents number of individual animals. NA, not available.